Infectious disease: Kaiser Permanente: resistance test inproves HIV treatment outcome and cuts costs
Article Abstract:
Oakland, CA-based Kaiser Permanente conducted research that supports the importance for resistance testing in helping physicians choose the best HIV treatment regimen for individual patients.
Publisher: Adis International Ltd.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
Science & research, Immunology, Diagnostic Test Kits & Reagents
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Xtrana: SBIR bucks for chlamydia POC probes
Article Abstract:
Denver, CO-based Xtrana is the recipient of a Small Business Innovation Research (SBIR) Phase I grant from the National Institutes of Health (NIH) and Centers of disease Control andPrevention (CDC) to develop a nucleic acid-based detection system for Chlamydia trachomatis.
Publisher: Adis International Ltd.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
Research and Testing Services, Receipt of funds, DNA-Based Tests, Sexually Transmitted Disease R&D, DNA identification, Xtrana Inc., Sexually transmitted disease research
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Medical testing products
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.